Literature DB >> 28815319

Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease.

Yuji Sato1, Shouichi Fujimoto2, Tsuneo Konta3, Kunitoshi Iseki3, Toshiki Moriyama3, Kunihiro Yamagata3, Kazuhiko Tsuruya3, Ichiei Narita3, Masahide Kondo3, Masato Kasahara3, Yugo Shibagaki3, Koichi Asahi3, Tsuyoshi Watanabe3.   

Abstract

BACKGROUND: Anemia is common in chronic kidney disease (CKD) and may be associated with mortality in CKD patients. However, few studies have examined this relationship in Asian populations.
METHODS: A total of 62,931 Japanese people (age 64.0 ± 8.0 years; men 38.5%) were followed up from 2008 to 2012. Participants were divided into six groups in accordance with their estimated glomerular filtration rate (eGFR) (<45, 45-59, ≥60 mL/min/1.73 m2) and by hemoglobin levels (13.0 g/dL for men; 12.0 g/dL for women). Hazard ratio and confidence interval (CI) for mortality with a combination of eGFR and anemia were calculated. After matching using propensity score (PS) for anemia, survival analysis between anemic and non-anemic people, independent from some variables, including eGFR, was performed.
RESULTS: A total of 828 (1.3%) participants died (non-anemic vs. anemic, 1.2 vs. 2.3%, p < 0.01). Multivariable Cox analysis showed that, independent of eGFR levels, anemic people had significantly higher mortality. Anemic people were found to have significantly poorer survival than non-anemic people as per a log-rank test (p < 0.01) for the PS-matching cohort. Further stratified logistic analysis using PS in the overall cohort odds ratio (95% CI) showed 2.25 (1.89-2.67) with p < 0.01.
CONCLUSION: The results of the present study showed that anemia was an independent risk factor of all-cause mortality.

Entities:  

Keywords:  All-cause mortality; Anemia; Chronic kidney disease; Propensity score

Mesh:

Substances:

Year:  2017        PMID: 28815319     DOI: 10.1007/s10157-017-1468-8

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  25 in total

1.  U-shaped association between body mass index and proteinuria in a large Japanese general population sample.

Authors:  Yuji Sato; Shouichi Fujimoto; Tsuneo Konta; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2013-05-08       Impact factor: 2.801

2.  Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations.

Authors:  Yuji Sato; Shouichi Fujimoto; Tsuneo Konta; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Kenjiro Kimura; Ichiei Narita; Masahide Kondo; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-11-30       Impact factor: 2.801

3.  Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.

Authors:  Kunitoshi Iseki; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Tsuneo Konta; Masato Kasahara; Yugo Shibagaki; Hisako Yoshida; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2017-03-03       Impact factor: 2.801

4.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

5.  Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.

Authors:  B Daan Westenbrink; Erik Lipsic; Peter van der Meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Journal:  Eur Heart J       Date:  2007-06-17       Impact factor: 29.983

6.  Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.

Authors:  Jerome L Abramson; Claudine T Jurkovitz; Viola Vaccarino; William S Weintraub; William McClellan
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

7.  Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study.

Authors:  Claudine T Jurkovitz; Jerome L Abramson; L Viola Vaccarino; William S Weintraub; William M McClellan
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

8.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

Authors:  Yongmei Liu; Josef Coresh; Joseph A Eustace; J Craig Longenecker; Bernard Jaar; Nancy E Fink; Russell P Tracy; Neil R Powe; Michael J Klag
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.

Authors:  J Pascual; J L Teruel; J L Moya; F Liaño; M Jiménez-Mena; J Ortuño
Journal:  Clin Nephrol       Date:  1991-06       Impact factor: 0.975

View more
  13 in total

1.  Hypoxia inducible factor-prolyl hydroxylase inhibitors in anemic patients with non-dialysis dependent chronic kidney disease: a meta-analysis of randomized clinical trials.

Authors:  Mohamed M G Mohamed; Mosunmoluwa Oyenuga; Safia Shaikh; Abayomi Oyenuga; Babikir Kheiri; Christian Nwankwo
Journal:  Int Urol Nephrol       Date:  2022-07-19       Impact factor: 2.266

2.  Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD.

Authors:  Masaomi Nangaku; Kazuoki Kondo; Yoshimasa Kokado; Kiichiro Ueta; Genki Kaneko; Tsubasa Tandai; Yutaka Kawaguchi; Yasuhiro Komatsu
Journal:  J Am Soc Nephrol       Date:  2021-04-21       Impact factor: 14.978

3.  Factors associated with survival in dogs with chronic kidney disease.

Authors:  Adam J Rudinsky; Laura M Harjes; Julie Byron; Dennis J Chew; Ramiro E Toribio; Catherine Langston; Valerie J Parker
Journal:  J Vet Intern Med       Date:  2018-10-16       Impact factor: 3.333

4.  JR-131, a Biosimilar of Darbepoetin Alfa, for the Treatment of Hemodialysis Patients With Renal Anemia: A Randomized, Double-Blinded, Parallel-Group Phase 3 Study.

Authors:  Shinichi Nishi; Masayuki Yamada; Kazuhiko Tsuruya; Ikuto Masakane; Hidetomo Nakamoto
Journal:  Ther Apher Dial       Date:  2019-08-21       Impact factor: 1.762

5.  Diagnosis Patterns of CKD and Anemia in the Japanese Population.

Authors:  Tomomi Kimura; Robert Snijder; Kazutoshi Nozaki
Journal:  Kidney Int Rep       Date:  2020-04-10

6.  Long-Term Safety and Efficacy of JR-131, a Biosimilar of Darbepoetin Alfa, in Japanese Patients With Renal Anemia Undergoing Hemodialysis: Phase 3 Prospective Study.

Authors:  Shinichi Nishi; Masayuki Yamada; Kazuhiko Tsuruya; Ikuto Masakane; Hidetomo Nakamoto
Journal:  Ther Apher Dial       Date:  2019-08-19       Impact factor: 1.762

7.  Impact of Metabolic Syndrome on the Mortality Rate among Participants in a Specific Health Check and Guidance Program in Japan.

Authors:  Kunitoshi Iseki; Tsuneo Konta; Koichi Asahi; Kunihiro Yamagata; Shouichi Fujimoto; Kazuhiko Tsuruya; Ichiei Narita; Masato Kasahara; Yugo Shibagaki; Toshiki Moriyama; Masahide Kondo; Chiho Iseki; Tsuyoshi Watanabe
Journal:  Intern Med       Date:  2020-07-14       Impact factor: 1.271

8.  Low serum iron is associated with anemia in CKD stage 1-4 patients with normal transferrin saturations.

Authors:  Pei-Hua Yu; Ming-Yen Lin; Yi-Wen Chiu; Jia-Jung Lee; Shang-Jyh Hwang; Chi-Chih Hung; Hung-Chun Chen
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

Review 9.  Challenging patient phenotypes in the management of anaemia of chronic kidney disease.

Authors:  Sheena Pramod; David S Goldfarb
Journal:  Int J Clin Pract       Date:  2021-08-12       Impact factor: 3.149

10.  Acute on chronic kidney disease in dogs: Etiology, clinical and clinicopathologic findings, prognostic markers, and survival.

Authors:  Asia Dunaevich; Hilla Chen; Danielle Musseri; Sharon Kuzi; Michal Mazaki-Tovi; Itamar Aroch; Gilad Segev
Journal:  J Vet Intern Med       Date:  2020-10-12       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.